Foreign medical laboratory scientists cannot operate an in-vitro diagnostic kit assembly plant in Nigeria without formal approval, premises inspection, and validation certification from the Medical Laboratory Science Council of Nigeria (MLSCN). Operating an assembly or packaging plant for rapid test kits, reagent strips, or diagnostic chemistry analyzers without prior MLSCN authorization violates federal health statutes, exposing the promoters to criminal prosecution, facility closure, and product impoundment under the Medical Laboratory Science Council of Nigeria Act 2003.
The Medical Laboratory Science Council of Nigeria derives its statutory regulatory mandate from Act No. 11 of 2003 (now Cap M25, Laws of the Federation of Nigeria). Under Section 4 and Section 19 of the statute, the MLSCN is empowered to regulate the practice of medical laboratory science, license practitioners, and oversee the production, importation, sales, and stocking of diagnostic reagents, laboratory test kits, and chemical consumables. The law leaves no loophole for foreign investors attempting to bypass professional oversight through corporate shell entities.
While the Companies and Allied Matters Act (CAMA) 2020 and the Nigerian Investment Promotion Commission (NIPC) Act permit foreign investors to own one hundred percent equity in Nigerian manufacturing companies, professional healthcare assembly remains strictly regulated. A foreign investor can establish a private limited liability company through the Corporate Affairs Commission (CAC) with an issued share capital of at least one hundred million Naira as mandated for foreign-owned entities by the Ministry of Interior. However, CAC incorporation merely provides corporate legal status; it does not confer a license to manufacture medical diagnostics.
Foreign laboratory scientists seeking to practice or manage production lines in Nigeria must possess valid professional accreditation. Foreign credentials must be evaluated by the MLSCN board, and foreign scientists must secure temporary registration or expatriate practice permits. In practice, foreign assembly ventures must appoint a registered Nigerian Medical Laboratory Scientist of good standing with an active annual practicing license as the designated Technical Director and production supervisor.
Furthermore, in-vitro diagnostic kit assembly in Nigeria entails dual regulatory compliance involving both the MLSCN and the National Agency for Food and Drug Administration and Control (NAFDAC). While MLSCN validates laboratory efficacy, analytical specificity, and batch reproducibility, NAFDAC registers the finished IVD product under the Food, Drugs and Related Products (Registration, etc.) Act. Both agencies perform independent factory audits.
Step-by-step regulatory licensing procedure for foreign IVD assembly plants:
- Incorporate a private limited liability company with CAC having explicit object clauses covering in-vitro diagnostic manufacturing and assembly.
- Register the company with the Nigerian Investment Promotion Commission and obtain a formal NIPC Business Permit.
- Appoint an MLSCN-licensed Medical Laboratory Scientist holding a current practicing license as the resident Head of Quality Assurance and Technical Operations.
- Submit architectural schematics, cleanroom specifications, HVAC filtration schematics, and standard operating procedures to the MLSCN Headquarters.
- Undergo on-site MLSCN pre-production inspection assessing cleanroom integrity, water purification systems, cold-chain storage facilities, and precision filling equipment.
- Produce test assembly batches under regulatory observation and submit representative samples to the MLSCN Public Health In-Vitro Diagnostic Laboratory for analytical validation.
- Receive the official MLSCN IVD validation certificate and manufacturing premises license upon confirmation of diagnostic sensitivity and specificity thresholds.
- Complete parallel registration dossiers with NAFDAC to obtain product registration numbers before commencing commercial distribution.
Regulatory division of responsibilities across oversight authorities:
- Medical Laboratory Science Council of Nigeria (MLSCN): Inspects assembly premises, evaluates reagent stability, validates analytical diagnostic accuracy, and disciplines professional technical staff.
- National Agency for Food and Drug Administration and Control (NAFDAC): Issues medical device registration numbers, regulates packaging labels, and conducts post-market surveillance.
- Corporate Affairs Commission (CAC): Registers the corporate vehicle, verifies statutory filings, and maintains the corporate register under CAMA 2020.
- Nigeria Immigration Service (NIS): Inspects expatriate quota approvals, issues CERPAC residency cards, and enforces alien work restrictions.
Operating without MLSCN validation triggers severe statutory sanctions under Section 22 of the MLSCN Act, including fines, confiscation of imported raw materials, and imprisonment of factory managers. Expatriate staff caught operating unlicensed laboratory production facilities are liable to immediate deportation under the Immigration Act 2015. International diagnostic firms must establish direct alignment with MLSCN before shipping automated assembly machinery into Nigerian territory.